John W. Park

Holistic Medicine

2339 1/2 Honolulu Ave
Montrose, CA 91020

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series.

Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series.

Journal: The oncologist

Published: October 11, 2023

Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer.

Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer.

Journal: Breast cancer research and treatment

Published: July 27, 2023

Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis.

Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis.

Journal: NPJ breast cancer

Published: May 05, 2023

A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.

A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.

Journal: Breast cancer research and treatment

Published: April 10, 2023

Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.

Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.

Journal: Breast cancer research and treatment

Published: September 26, 2022

Response by Park et al to Letter Regarding Article, "Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure".

Response by Park et al to Letter Regarding Article, "Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure".

Journal: Circulation. Heart failure

Published: June 29, 2022

The Transcriptome Profile of Retinal Pigment Epithelium and Müller Cell Lines Protected by Risuteganib Against Hydrogen Peroxide Stress.

The Transcriptome Profile of Retinal Pigment Epithelium and Müller Cell Lines Protected by Risuteganib Against Hydrogen Peroxide Stress.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: June 22, 2022

Palladium-Catalyzed Aryldifluoromethylation of Aryl Halides with Aryldifluoromethyl Trimethylsilanes.

Palladium-Catalyzed Aryldifluoromethylation of Aryl Halides with Aryldifluoromethyl Trimethylsilanes.

Journal: Angewandte Chemie (International ed. in English)

Published: June 03, 2022

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.

Journal: NPJ breast cancer

Published: September 12, 2021

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.

Journal: NPJ breast cancer

Published: December 29, 2020

Risuteganib Protects against Hydroquinone-induced Injury in Human RPE Cells.

Risuteganib Protects against Hydroquinone-induced Injury in Human RPE Cells.

Journal: Investigative ophthalmology & visual science

Published: August 21, 2020

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

Journal: JAMA oncology

Published: July 24, 2020

Showing 1-12 of 60

Last Updated: 09/26/2026